Literature DB >> 24328742

Murine b7-h3 is a co-stimulatory molecule for T cell activation.

Ruhong Yan1, Shun Yang, Aiping Gu, Fuqin Zhan, Chunyan He, Chenhao Qin, Xueguang Zhang, Ping Feng.   

Abstract

The B7 family member B7-H3 (CD276) plays a key role during an immune response but its function remains controversial. In this study, we found that murine B7-H3 up-regulated the proliferation and cytokine production of T cells. Our study suggested that there was no interaction of murine B7-H3 with a triggering receptor expressed on myeloid cells (TREM)-like transcript 2 (TLT-2). Further studies demonstrated that mouse B7-H3 specifically bound to T cells and its receptor was not murine TLT-2. Moreover, murine B7-H3 was a positive co-stimulatory molecule in the regulation of T cell-mediated immune responses.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24328742      PMCID： PMC3869539          DOI： 10.1089/mab.2013.0052

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN： 2167-9436


  16 in total

1.  Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells.

Authors:  G-B Zhang; H Zhou; Y-J Chen; Y Ge; F Xie; Q Shi; H-B Ma; M Fei; X-G Zhang
Journal:  Tissue Antigens       Date:  2005-08

2.  B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

Authors:  A I Chapoval; J Ni; J S Lau; R A Wilcox; D B Flies; D Liu; H Dong; G L Sica; G Zhu; K Tamada; L Chen
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

3.  B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.

Authors:  Liqun Luo; Andrei I Chapoval; Dallas B Flies; Gefeng Zhu; Fumiya Hirano; Shengdian Wang; Julie S Lau; Haidong Dong; Koji Tamada; Andrew S Flies; Yang Liu; Lieping Chen
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

4.  Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.

Authors:  Peter Steinberger; Otto Majdic; Sophia V Derdak; Katharina Pfistershammer; Stefanie Kirchberger; Christoph Klauser; Gerhard Zlabinger; Winfried F Pickl; Johannes Stöckl; Walter Knapp
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

5.  Characterization of mouse and human B7-H3 genes.

Authors:  Mingyi Sun; Sabrina Richards; Durbaka V R Prasad; Xoi Muoi Mai; Alexander Rudensky; Chen Dong
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

6.  The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses.

Authors:  Woong-Kyung Suh; Beata U Gajewska; Hitoshi Okada; Matthew A Gronski; Edward M Bertram; Wojciech Dawicki; Gordon S Duncan; Jacob Bukczynski; Suzanne Plyte; Andrew Elia; Andrew Wakeham; Annick Itie; Stephen Chung; Joan Da Costa; Sudha Arya; Tom Horan; Pauline Campbell; Kevin Gaida; Pamela S Ohashi; Tania H Watts; Steven K Yoshinaga; Mark R Bray; Manel Jordana; Tak W Mak
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

7.  Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.

Authors:  Guangbo Zhang; Jianquan Hou; Jinfang Shi; Gehua Yu; Binfeng Lu; Xueguang Zhang
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

8.  B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.

Authors:  Timothy J Roth; Yuri Sheinin; Christine M Lohse; Susan M Kuntz; Xavier Frigola; Brant A Inman; Amy E Krambeck; Maureen E McKenney; R Jeffrey Karnes; Michael L Blute; John C Cheville; Thomas J Sebo; Eugene D Kwon
Journal:  Cancer Res       Date:  2007-08-08       Impact factor: 12.701

9.  Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss.

Authors:  Vincent Ling; Paul W Wu; Vikki Spaulding; Jan Kieleczawa; Deborah Luxenberg; Beatriz M Carreno; Mary Collins
Journal:  Genomics       Date:  2003-09       Impact factor: 5.736

10.  Murine B7-H3 is a negative regulator of T cells.

Authors:  Durbaka V R Prasad; Thang Nguyen; Zhaoxia Li; Yang Yang; Julie Duong; Ying Wang; Chen Dong
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422
View more
  11 in total

1.  Involvement of soluble B7-H3 in combination with the serum inflammatory cytokines interleukin-17, -8 and -6 in the diagnosis of hepatocellular carcinoma.

Authors:  Fenghuang Xu; Junzhu Yi; Feifei Wang; Weiwei Wang; Zhuoya Wang; Jiangnan Xue; Xiying Luan
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

2.  Soluble B7-H3 in Ovarian Cancer and Its Predictive Value.

Authors:  O V Kovaleva; T P Belova; E A Korotkova; D N Kushlinskii; A N Gratchev; N A Petrikova; D A Kudlay; N E Kushlinskii
Journal:  Bull Exp Biol Med       Date:  2021-09-20       Impact factor: 0.804

3.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

Review 4.  Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups.

Authors:  Lawrence P Andrews; Hiroshi Yano; Dario A A Vignali
Journal:  Nat Immunol       Date:  2019-10-14       Impact factor: 25.606

5.  Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis.

Authors:  Jianxiang Song; Woda Shi; Yajun Zhang; Mingzhong Sun; Xiaodong Liang; Shiying Zheng
Journal:  Onco Targets Ther       Date:  2016-10-12       Impact factor: 4.147

Review 6.  Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.

Authors:  Tao Shi; Yanyu Ma; Lingfeng Yu; Jiaxuan Jiang; Sunan Shen; Yayi Hou; Tingting Wang
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

7.  A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276.

Authors:  Xiaobo Yu; Bajin Wei; Rong Su; Jia Yao; Xiaowen Feng; Guoping Jiang; Haiyang Xie; Jian Wu; Xiao Xu; Min Zhang; Shusen Zheng; Lin Zhou
Journal:  Mol Genet Genomic Med       Date:  2019-05-01       Impact factor: 2.183

8.  Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research.

Authors:  Lidia Tarone; Davide Giacobino; Mariateresa Camerino; Soldano Ferrone; Paolo Buracco; Federica Cavallo; Federica Riccardo
Journal:  Front Vet Sci       Date:  2022-02-11

9.  Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.

Authors:  Carlo Genova; Simona Boccardo; Marco Mora; Erika Rijavec; Federica Biello; Giovanni Rossi; Marco Tagliamento; Maria Giovanna Dal Bello; Simona Coco; Angela Alama; Irene Vanni; Giulia Barletta; Rita Bianchi; Claudia Maggioni; Paolo Bruzzi; Francesco Grossi
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

Review 10.  Alternative Checkpoints as Targets for Immunotherapy.

Authors:  Ayush Pant; Ravi Medikonda; Michael Lim
Journal:  Curr Oncol Rep       Date:  2020-11-03       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.